Jul 01, 2019
3:2
For every 2 shares held, investors received 3. The price per share adjusted from $77.10 to $51.40.
The split itself did not change the total investment value.
Hangzhou Tigermed Consulting Co., Ltd. Class A (SZSE:300347) operates in the Biotechnology industry.
Hangzhou Tigermed Consulting Co., Ltd. Class A company overviewHangzhou Tigermed Consulting Co., Ltd. Class A's most recent stock split was on July 1, 2019. It was a 3-for-2 forward split, so shareholders received 3 shares for every 2 they held.
Hangzhou Tigermed Consulting Co., Ltd. Class A (SZSE:300347) has split its stock 4 times: a 2-for-1 split on May 2, 2013, a 2-for-1 split on May 7, 2014, a 2-for-1 split on May 20, 2015, and a 3-for-2 split on July 1, 2019.
Hangzhou Tigermed Consulting Co., Ltd. Class A has split its stock 4 times. This history records 4 forward splits between May 2, 2013 and July 1, 2019.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hangzhou Tigermed Consulting Co., Ltd. Class A's 3-for-2 split on July 1, 2019, every 2 shares became 3 shares.
Hangzhou Tigermed Consulting Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on July 1, 2019, 7 years ago. Companies announce splits in advance, and any new SZSE:300347 split will appear on this page.
Already premium?